Cover Image

Il Fibroblast Growth Factor-23 (FGF-23)

Negli ultimi due decenni, l'identificazione delle proprietà biologiche del Fibroblast Growth Factor 23 (FGF23) ha notevolmente ampliato le conoscenze sulla regolazione endocrina e paracrina dell'omeostasi dei fosfati e sulle relazioni intercorrenti tra asse rene-intestino-tessuto osseo e...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. Rendina (Author), G. De Filippo (Author), R. Muscariello (Author), F. De Pascale (Author), P. Strazzullo (Author)
Format:	Book
Published:	AboutScience Srl, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale
by: Luca Di Lullo, et al.
Published: (2015)

Impact of Osteocalcin Level on Vascular Calcification in Type 2 Diabetics in Relation to Fibroblast Growth Factor-23(FGF-23)
by: Inas A. Ali, et al.
Published: (2018)

PILOTSTUDY TO EVALUATE THE EFFECT OF PHOSPHORUSBINDERS ON FGF23
by: A.Bouma de Krijger, et al.
Published: (2012)

Caratteristiche cliniche dei pazienti con sindrome metabolica e nefrolitiasi recidivante da ossalato di calcio
by: F. De Pascale, et al.
Published: (2018)

Alcoholism, Fibroblast Growth Factor 23 and Cardiovascular Risk
by: Emilio González-Reimers, et al.
Published: (2017)

Phosphate Homeostasis, Inflammation and the Regulation of FGF-23
by: Florian Lang, et al.
Published: (2018)

Fibroblast growth factor 23 levels before and after renal transplantation
by: Mohamed M El-khatib, et al.
Published: (2016)

Tumor-induced osteomalacia: Easing the diagnosis with fibroblast growth factor 23
by: Mala Dharmalingam, et al.
Published: (2022)

Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension
by: Yao Lin, et al.
Published: (2019)

Revisione critica della letteratura internazionale di pertinenza internistica prodotta nel biennio 2007-2008 sul tema della nefrolitiasi
by: D. Rendina, et al.
Published: (2018)

FGF-23, Klotho and Vitamin D Levels in Scleroderma
by: Ravan AHMADI, et al.
Published: (2017)

Does fibroblast growth factor 23 correlates with volume status in hemodialysis patients?
by: Farzanehsadat Minoo, et al.
Published: (2019)

Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
Published: (2019)

Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia
by: Elis J. Lira dos Santos, et al.
Published: (2023)

Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity
by: Sandra Llorente-Pelayo, et al.
Published: (2024)

Fibroblast growth factor 23 in children with or without heart failure: a prospective study
by: Rania Salah Elzayat, et al.
Published: (2023)

Il dosaggio del FGF23 con metodica automatizzata: un'esperienza monocentrica nella malattia renale cronica
by: Caterina Pelosini, et al.
Published: (2019)

Impact of Annexin A 7 Deficiency on FGF23 Plasma Concentrations
by: Anja T. Umbach, et al.
Published: (2016)

La Dieta Iposodica Riduce L'indice di Sovrasaturazione Urinaria Dei Sali di Ossalato di Calcio (AP-CaOx) Nei Pazienti Con Nefrolitiasi Ossalato-Calcica e Sindrome Metabolica
by: Francesca De Pascale, et al.
Published: (2017)

Assessment of fibroblast growth factor 23 in relation to peripheral arterial disease in type 2 diabetes mellitus
by: Mohamed R Halawa, et al.
Published: (2019)

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease-A Pediatric Perspective
by: Andrea Grund, et al.
Published: (2021)

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
by: Xenophon Kassianides, et al.
Published: (2021)

Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
by: Olena Zaitseva, et al.
Published: (2022)

The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease
by: Melahat Coban, et al.
Published: (2018)

Impact of fibroblast growth factor-23 on blood pressure and pulse pressure in hemodialysis patients; a multicenter study
by: Farzanehsadat , Minoo, et al.
Published: (2019)

Fibroblast Growth Factor (FGF) Receptor Mutations: A Pathway to Understanding Multigenic Risk in Disease?
by: Stuart J. Mires
Published: (2013)

Fibroblast Growth Factor (FGF) Receptor Mutations: A Pathway to Understanding Multigenic Risk in Disease?
by: Stuart J. Mires
Published: (2013)

C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population
by: Maria Bożentowicz-Wikarek, et al.
Published: (2016)

Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients
by: Eleni Manou, et al.
Published: (2020)

Association of serum fibroblast growth factor 23 with calcium metabolism in patients with end-stage renal disease undergoing hemodialysis
by: Niloufar Alimohammadi, et al.
Published: (2017)

Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2
by: Nina Bon, et al.
Published: (2018)

Targeting IL-23 in psoriasis: current perspectives
by: Fotiadou C, et al.
Published: (2018)

PLASMA EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND BASIC FIBROBLAST GROWTH FACTOR (bFGF) IN PATIENTS WITH BRAIN TUMORS.
by: Deyan Handzhiev, et al.
Published: (2015)

In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions
by: Leah Benington, et al.
Published: (2024)

Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt
by: LaRae Seemann BS, et al.
Published: (2019)

Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
by: Zhenjiang Bai, et al.
Published: (2018)

Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review
by: Amina M. Alieva, et al.
Published: (2024)

C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro
by: Wei Xia Chen, et al.
Published: (2020)

Correlation of serum soluble Klotho with fibroblast growth factor 23 levels in chronic kidney disease patients; a single centre study
by: Yuvaraj Anand, et al.
Published: (2020)

La Gestione Clinica Del Paziente Con Nefrolitiasi: Sono Necessari Trials Ad Hoc
by: Domenico Rendina, et al.
Published: (2018)